Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $209.78M | $262.02M | 72.85% | +$52.25M |
| Verona Pharma plc (VRNA)ADS | 615,352 | 615,352 | 0 | $39.07M | $58.20M | 16.18% | +$19.13M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,316,806 | +291,806 | $12.59M | $12.33M | 3.43% | -$261.7K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $6.83M | $6.64M | 1.85% | -$191.4K |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $7.41M | $5.29M | 1.47% | -$2.13M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $4.47M | $4.95M | 1.38% | +$482.8K |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 2,048,757 | +1,250,000 | $1.70M | $3.69M | 1.03% | +$1.99M |
| COMPASS Pathways plcADS(CMPS) | 1,198,418 | 1,198,418 | 0 | $3.43M | $3.36M | 0.93% | -$71.9K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $734.5K | $1.04M | 0.29% | +$306.2K |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $995.3K | $833.8K | 0.23% | -$161.5K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $664.7K | $616.9K | 0.17% | -$47.8K |
| Marker Therapeutics, Inc.(MRKR) | 325,370 | 325,370 | 0 | $400.2K | $497.8K | 0.14% | +$97.6K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 88,607 | 88,607 | 0 | $381.0K | $211.8K | 0.06% | -$169.2K |